• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脂异常基因检测的临床影响。

Clinical impact of genetic testing for lipid disorders.

机构信息

Department of Internal Medicine, Endocrinology Section, Clinical Centre of Montenegro.

Faculty of Medicine, University of Montenegro, Podgorica, Montenegro.

出版信息

Curr Opin Cardiol. 2024 May 1;39(3):154-161. doi: 10.1097/HCO.0000000000001133. Epub 2024 Feb 29.

DOI:10.1097/HCO.0000000000001133
PMID:38456469
Abstract

PURPOSE OF REVIEW

Genetic testing is increasingly becoming a common consideration in the clinical approach of dyslipidemia patients. Advances in research in last decade and increased recognition of genetics in biological pathways modulating blood lipid levels created a gap between theoretical knowledge and its applicability in clinical practice. Therefore, it is very important to define the clinical justification of genetic testing in dyslipidemia patients.

RECENT FINDINGS

Clinical indications for genetic testing for most dyslipidemias are not precisely defined and there are no clearly established guideline recommendations. In patients with severe low-density lipoprotein cholesterol (LDL-C) levels, the genetic analysis can be used to guide diagnostic and therapeutic approach, while in severe hypertriglyceridemia (HTG), clinicians can rely on triglyceride level rather than a genotype along the treatment pathway. Genetic testing increases diagnostic accuracy and risk stratification, access and adherence to specialty therapies, and cost-effectiveness of cascade testing. A shared decision-making model between the provider and the patient is essential as patient values, preferences and clinical characteristics play a very strong role.

SUMMARY

Genetic testing for lipid disorders is currently underutilized in clinical practice. However, it should be selectively used, according to the type of dyslipidemia and when the benefits overcome costs.

摘要

目的综述

基因检测在血脂异常患者的临床处理中越来越受到重视。过去十年中,研究的进展和对调节血脂水平的生物学途径的遗传学认识的提高,使得理论知识与其在临床实践中的应用之间存在差距。因此,明确血脂异常患者基因检测的临床适应证非常重要。

最近的发现

大多数血脂异常的基因检测临床适应证尚未明确界定,也没有明确的指南推荐。在严重低密度脂蛋白胆固醇(LDL-C)水平的患者中,基因分析可用于指导诊断和治疗方法,而在严重高甘油三酯血症(HTG)中,临床医生可以根据治疗途径中的甘油三酯水平而非基因型进行治疗。基因检测可提高诊断准确性和风险分层、获得和坚持专科治疗的机会,以及级联检测的成本效益。提供者和患者之间的共同决策模型至关重要,因为患者的价值观、偏好和临床特征起着非常重要的作用。

总结

目前,基因检测在血脂异常的临床实践中应用不足。然而,它应该根据血脂异常的类型以及获益是否超过成本进行有选择地应用。

相似文献

1
Clinical impact of genetic testing for lipid disorders.血脂异常基因检测的临床影响。
Curr Opin Cardiol. 2024 May 1;39(3):154-161. doi: 10.1097/HCO.0000000000001133. Epub 2024 Feb 29.
2
PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations.PCSK9 抑制剂和依折麦布降低心血管事件风险的临床实践指南:基于风险分层的推荐意见。
BMJ. 2022 May 4;377:e069066. doi: 10.1136/bmj-2021-069066.
3
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].[支气管哮喘防治指南(2024年版)]
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.不同吸入性糖皮质激素及其与长效β2受体激动剂联合使用治疗12岁及以上成人和儿童慢性哮喘比较效果的系统评价与经济学分析
Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. doi: 10.3310/hta12190.
6
Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline.不宁腿综合征和周期性肢体运动障碍的治疗:美国睡眠医学学会临床实践指南
J Clin Sleep Med. 2025 Jan 1;21(1):137-152. doi: 10.5664/jcsm.11390.
7
Familial Hypercholesterolemia家族性高胆固醇血症
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
10
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.